A carregar...
Epigenetic silencing of MEIS2 in prostate cancer recurrence
BACKGROUND: Current diagnostic and prognostic tools for prostate cancer (PC) are suboptimal, resulting in overdiagnosis and overtreatment of clinically insignificant tumors. Thus, to improve the management of PC, novel biomarkers are urgently needed. RESULTS: In this study, we integrated genome-wide...
Na minha lista:
| Publicado no: | Clin Epigenetics |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6805635/ https://ncbi.nlm.nih.gov/pubmed/31640805 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-019-0742-x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|